Vivos Therapeutics Inc (VVOS)

03:18 AM

Vivos Therapeutics, Inc. (NASDAQ:VVOS) Receives Consensus Recommendation of “Hold” from Analysts - Defense World

03:18 AM

Dec 11, 2025

Vivos Therapeutics Inc Stock Analysis and ForecastBull Market Opportunities & Use Our Sector Rotation Strategy for Gains - earlytimes.in

Dec 11, 2025

Dec 07, 2025

What analysts say about Vivos Therapeutics Inc stockPrice Momentum Alerts & What the Pros Are Saying About This Stock - earlytimes.in

Dec 07, 2025

Dec 06, 2025

Vivos Therapeutics secures $2M note with Avondale - MSN

Dec 06, 2025

Dec 05, 2025

Vivos Therapeutics Secures $2M Note with Avondale - TipRanks

Dec 05, 2025

Dec 05, 2025

Vivos Therapeutics, Inc. Enters into a Note Purchase Agreement with Avondale Capital, LLC - marketscreener.com

Dec 05, 2025

Dec 05, 2025

Can Vivos Therapeutics Inc. stock beat analyst upgradesJuly 2025 Closing Moves & High Accuracy Swing Entry Alerts - Newser

Dec 05, 2025

Dec 05, 2025

Is Vivos Therapeutics Inc. stock a buy for dividend growthEarnings Overview Summary & Low Drawdown Momentum Trade Ideas - Newser

Dec 05, 2025

Dec 04, 2025

Vivos Therapeutics, Inc. announced that it has received $2.09334 million in funding from Avondale Capital, LP - marketscreener.com

Dec 04, 2025

Dec 04, 2025

Vivos Therapeutics (NASDAQ:VVOS) Given New $5.50 Price Target at Ascendiant Capital Markets - Defense World

Dec 04, 2025

Dec 04, 2025

Is Vivos Therapeutics Inc. stock a smart buy before Fed meeting2025 Price Momentum & AI Enhanced Trading Alerts - Newser

Dec 04, 2025

Dec 03, 2025

VVOS: Ascendiant Capital Maintains Buy Rating, Lowers Price Targ - GuruFocus

Dec 03, 2025

Dec 03, 2025

Ascendiant Capital Maintains Vivos Therapeutics (VVOS) Buy Recommendation - Nasdaq

Dec 03, 2025

Dec 03, 2025

Vivos Therapeutics (VVOS) Stock Analysis Report | Ratings, Financials & Performance - Benzinga

Dec 03, 2025

Dec 01, 2025

Vivos Therapeutics Reports Strong Q3 Growth Amid Challenges - MSN

Dec 01, 2025

Dec 01, 2025

Best Biotech Penny Stocks Right Now • Updated Daily - Benzinga

Dec 01, 2025

Nov 26, 2025

Vivos Therapeutics Inc (VVOS) Q3 2025 Earnings Call Highlights: Revenue Surge Amid Strategic ... By GuruFocus - Investing.com Canada

Nov 26, 2025

Nov 21, 2025

Why Vivos Therapeutics Inc. stock remains on buy lists2025 Geopolitical Influence & High Accuracy Investment Signals - newser.com

Nov 21, 2025

Nov 21, 2025

Vivos Therapeutics, Inc. (NASDAQ:VVOS) Q3 2025 Earnings Call Transcript - Insider Monkey

Nov 21, 2025

Nov 20, 2025

Vivos Therapeutics Inc. (VVOS) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade

Nov 20, 2025

Nov 20, 2025

Vivos Therapeutics Rides Acquisition Wave To Higher Revenue - Finimize

Nov 20, 2025

Nov 20, 2025

What is HC Wainwright’s Estimate for VVOS Q3 Earnings? - Defense World

Nov 20, 2025

Nov 20, 2025

Vivos Therapeutics, Inc. (NASDAQ:VVOS) Receives $5.44 Average Target Price from Analysts - Defense World

Nov 20, 2025

Nov 20, 2025

Vivos Therapeutics Reports Revenue Growth Amid Strategic Shift - MSN

Nov 20, 2025

Nov 20, 2025

Published on: 2025-11-20 02:04:52 - newser.com

Nov 20, 2025

Nov 20, 2025

Vivos Therapeutics Reports Significant Revenue Growth During the Third Quarter 2025 - The Manila Times

Nov 20, 2025

Nov 20, 2025

Earnings call transcript: Vivos Therapeutics Q3 2025 shows revenue growth By Investing.com - Investing.com Nigeria

Nov 20, 2025

Nov 20, 2025

Vivos Therapeutics signals continued revenue acceleration amid SCN integration and SAMC expansion plans - MSN

Nov 20, 2025

Nov 19, 2025

Vivos Therapeutics Q3 2025 Earnings Call Transcript - MarketBeat

Nov 19, 2025

Nov 19, 2025

Why Vivos Therapeutics Inc. stock appeals to analystsFed Meeting & Technical Confirmation Alerts - newser.com

Nov 19, 2025

Nov 19, 2025

Earnings call transcript: Vivos Therapeutics Q3 2025 shows revenue growth - Investing.com India

Nov 19, 2025

Nov 19, 2025

What technical charts say about Vivos Therapeutics Inc. stockWeekly Gains Summary & Verified Entry Point Signals - newser.com

Nov 19, 2025

Nov 19, 2025

[8-K] Vivos Therapeutics, Inc. Reports Material Event | VVOS SEC FilingForm 8-K - Stock Titan

Nov 19, 2025

Nov 19, 2025

Vivos Therapeutics Q3 revenue rises, helped by SCN acquisition - marketscreener.com

Nov 19, 2025

Nov 19, 2025

Will Vivos Therapeutics Inc. continue its uptrendTake Profit & Verified Swing Trading Watchlist - newser.com

Nov 19, 2025

Nov 19, 2025

Vivos Therapeutics (NASDAQ: VVOS) reports 78% third quarter revenue growth - Stock Titan

Nov 19, 2025

Nov 19, 2025

[10-Q] Vivos Therapeutics, Inc. Quarterly Earnings Report | VVOS SEC FilingForm 10-Q - Stock Titan

Nov 19, 2025

Nov 19, 2025

Vivos Therapeutics, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2025 - MarketScreener

Nov 19, 2025

Nov 19, 2025

Vivos Therapeutics, Inc. Plans Q3 2025 Financial Results Release and Investor Conference Call - Quiver Quantitative

Nov 19, 2025

Nov 19, 2025

Vivos Therapeutics (NASDAQ: VVOS) to Release Q3 2025 Results, Host Call Today - Stock Titan

Nov 19, 2025